MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
IDEXX Laboratories Depreciation & Amortization 2011-2026 | IDXX
Annual Depreciation & Amortization IDEXX Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 130 M | 115 M | 112 M | 105 M | 96 M | 88 M | 83.2 M | 83.1 M | 78.2 M | 69 M | 58.9 M | 54.6 M | 52.4 M | 48.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 130 M | 48.2 M | 83.8 M |
Quarterly Depreciation & Amortization IDEXX Laboratories
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 34.1 M | - | - | - | 29.9 M | - | - | - | 28.3 M | - | 83.2 M | - | 26.5 M | - | 76.9 M | - | 25.1 M | - | 71.4 M | 46.8 M | 23.2 M | - | 65.4 M | 43 M | 21.4 M | - | 62.6 M | 41.7 M | 20.8 M | - | 61.6 M | 40.9 M | 20.3 M | - | 58 M | 38.2 M | 18.5 M | - | 51.2 M | 32.9 M | 16.2 M | - | 43.6 M | 28.1 M | 13.4 M | - | 41.1 M | 27.4 M | 13.5 M | - | 38.5 M | 25.7 M | 12.7 M | - | 35.4 M | 23.3 M | 11.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 83.2 M | 11.5 M | 36.5 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 20.15 | -2.3 % | $ 217 M |  China |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.23 M | $ 0.17 | -6.7 % | $ 4.99 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 38.9 | -1.04 % | $ 1.08 B | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.53 | 2.0 % | $ 1.94 M | USA |
 |
Danaher Corporation
DHR
|
721 M | $ 228.92 | -0.76 % | $ 167 B | USA |
 |
DexCom
DXCM
|
186 M | $ 66.37 | -1.03 % | $ 25.6 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 11.38 | 6.36 % | $ 323 M |  Israel |
 |
Exact Sciences Corporation
EXAS
|
120 M | $ 101.56 | -0.33 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 26.27 | -0.83 % | $ 794 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 18.84 | -1.21 % | $ 1.01 B | USA |
 |
Celcuity
CELC
|
130 K | $ 99.74 | -0.18 % | $ 3.93 B | USA |
 |
IQVIA Holdings
IQV
|
1.11 B | $ 225.41 | -1.0 % | $ 40.9 B | USA |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 3.12 | - | $ 99.5 K | USA |
 |
Guardant Health
GH
|
42.4 M | $ 102.14 | 1.53 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Myriad Genetics
MYGN
|
61.2 M | $ 6.15 | -0.32 % | $ 557 M | USA |
 |
Illumina
ILMN
|
354 M | $ 131.16 | -1.2 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
362 M | $ 199.48 | -1.24 % | $ 10.2 B | USA |
 |
ENDRA Life Sciences
NDRA
|
46.5 K | $ 4.53 | -4.83 % | $ 2.43 M | USA |
 |
NeoGenomics
NEO
|
39.1 M | $ 11.76 | -3.84 % | $ 1.49 B | USA |
 |
National Research Corporation
NRC
|
140 K | $ 18.77 | 0.64 % | $ 461 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 173.53 | -1.12 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
5.77 M | $ 6.8 | 1.19 % | $ 882 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
644 M | $ 250.88 | -0.87 % | $ 21 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 182.22 | -0.43 % | $ 15 B |  Irlanda |
 |
Lantheus Holdings
LNTH
|
64.6 M | $ 66.55 | -0.91 % | $ 4.61 B | USA |
 |
Mettler-Toledo International
MTD
|
50.4 M | $ 1 394.19 | -1.42 % | $ 29.6 B |  Schweiz |
 |
Agilent Technologies
A
|
321 M | $ 136.07 | -1.13 % | $ 41.4 B | USA |
 |
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.52 | 2.86 % | $ 5.79 M | USA |
 |
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | USA |
 |
OPKO Health
OPK
|
98.2 M | $ 1.26 | -3.08 % | $ 874 M | USA |